CURE vs. RXL

Last updated Aug 2, 2026

CURE (Direxion Daily Healthcare Bull 3x Shares) and RXL (ProShares Ultra Health Care) are both Leveraged Equities funds - CURE tracks the Health Care Select Sector Index (300%) while RXL tracks the Dow Jones U.S. Health Care Index (200%). Both are passively managed. Over the past 10 years, CURE returned 13.35%/yr vs 12.62%/yr for RXL. Their 0.97 correlation means they have historically moved very closely together. CURE charges 0.94%/yr vs 0.95%/yr for RXL.

Performance

CURE vs. RXL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Healthcare Bull 3x Shares (CURE) and ProShares Ultra Health Care (RXL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both investments are quite close, with CURE having a 6.99% return and RXL slightly higher at 7.08%. Over the past 10 years, CURE has outperformed RXL with an annualized return of 13.35%, while RXL has yielded a comparatively lower 12.62% annualized return.

CURE

• 1D: -1.72%
• 1M: -3.56%
• 6M: 9.07%
• YTD: 6.99%
• 1Y: 68.66%
• 3Y*: 7.13%
• 5Y*: 0.86%
• 10Y*: 13.35%
• ALL TIME*: 24.24%

RXL

• 1D: -1.31%
• 1M: -2.22%
• 6M: 7.76%
• YTD: 7.08%
• 1Y: 46.85%
• 3Y*: 8.58%
• 5Y*: 2.44%
• 10Y*: 12.62%
• ALL TIME*: 14.64%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
CURE Direxion Daily Healthcare Bull 3x Shares	$8.40M	$9.61M	$9.25M
RXL ProShares Ultra Health Care	$1.09M	$939.16K	$589.20K

CURE vs. RXL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CURE Direxion Daily Healthcare Bull 3x Shares	6.99%	22.55%	-8.47%	-9.40%	-20.51%	88.30%	5.02%	55.66%	2.82%	69.32%
RXL ProShares Ultra Health Care	7.08%	19.76%	-2.72%	-3.15%	-15.26%	48.06%	19.24%	40.40%	3.38%	46.92%

Correlation

The correlation between CURE and RXL is 1.00 - they have historically moved very closely together. At this level, their price movements offset little of one another.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	1.00
Correlation (3Y) Balances recent behavior with more history.	0.99
Correlation (5Y) Shows whether the relationship held over a longer period.	0.99
Correlation (10Y) Provides a long-term view across more market conditions.	0.98
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011	0.97

The correlation between CURE and RXL has been stable across timeframes, ranging from 0.97 to 1.00 - a consistent structural relationship.

CURE vs. RXL - Sectors Allocation Comparison

Sectors	CURE	RXL
Healthcare	20.5%	71.0%
Technology	0.1%	0.3%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	10.1%
Industrials	-	-
Real Estate	-	-
Utilities	-	-

Return for Risk

CURE vs. RXL — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CURE

CURE Risk / Return Rank: 63
CURE Sharpe Ratio Rank: 69
CURE Sortino Ratio Rank: 73
CURE Omega Ratio Rank: 60
CURE Calmar Ratio Rank: 66
CURE Martin Ratio Rank: 46

RXL

RXL Risk / Return Rank: 63
RXL Sharpe Ratio Rank: 68
RXL Sortino Ratio Rank: 74
RXL Omega Ratio Rank: 62
RXL Calmar Ratio Rank: 66
RXL Martin Ratio Rank: 47

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CURE vs. RXL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and ProShares Ultra Health Care (RXL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CURE	RXL	Difference
Sharpe ratio: Return per unit of total volatility	1.56	1.56	+0.01
Sortino ratio: Return per unit of downside risk	2.34	2.39	-0.05
Omega ratio: Gain probability vs. loss probability	1.26	1.26	-0.01
Calmar ratio: Return relative to maximum drawdown	2.31	2.30	+0.02
Martin ratio: Return relative to average drawdown	5.20	5.30	-0.10

CURE vs. RXL - Sharpe Ratio Comparison

The current CURE Sharpe Ratio is 1.56, which is comparable to the RXL Sharpe Ratio of 1.56. The chart below compares the historical Sharpe Ratios of CURE and RXL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CURE vs. RXL - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, roughly equal to the maximum RXL drawdown of -67.70%. Use the drawdown chart below to compare losses from any high point for CURE and RXL.

Drawdown Indicators

	CURE	RXL	Difference
Max Drawdown Largest peak-to-trough decline	-69.19%	-67.70%	-1.49%
Max Drawdown (1Y) Largest decline over 1 year	-31.10%	-21.33%	-9.77%
Max Drawdown (3Y) Largest decline over 3 years	-51.93%	-36.08%	-15.85%
Max Drawdown (5Y) Largest decline over 5 years	-52.23%	-36.08%	-16.15%
Max Drawdown (10Y) Largest decline over 10 years	-69.19%	-51.00%	-18.19%
Current Drawdown Current decline from peak	-15.08%	-5.57%	-9.51%
Average Drawdown Average peak-to-trough decline	-18.17%	-15.78%	-2.39%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.82%	9.21%	+4.61%

Volatility

CURE vs. RXL - Volatility Comparison

Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 17.62% compared to ProShares Ultra Health Care (RXL) at 12.08%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than RXL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CURE	RXL	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.62%	12.08%	+5.54%
Volatility (6M) Calculated over the trailing 6-month period	35.23%	24.15%	+11.08%
Volatility (1Y) Calculated over the trailing 1-year period	46.92%	32.06%	+14.86%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	44.69%	30.29%	+14.40%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	49.85%	33.47%	+16.38%

CURE vs. RXL - Expense Ratio Comparison

CURE has a 0.94% expense ratio, which is lower than RXL's 0.95% expense ratio.

Dividends

CURE vs. RXL - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.06%, less than RXL's 1.28% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CURE Direxion Daily Healthcare Bull 3x Shares	1.06%	1.12%	1.17%	2.02%	0.38%	0.02%	0.17%	0.40%	0.70%	0.18%	0.00%	0.00%
RXL ProShares Ultra Health Care	1.28%	1.43%	1.22%	0.18%	0.32%	0.10%	0.15%	0.27%	0.32%	0.11%	0.12%	0.93%

Frequently Asked Questions

Can I hold both CURE and RXL in my portfolio?

With a correlation of 1.00, CURE and RXL move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.

Which is riskier, CURE or RXL?

CURE has higher volatility (17.62%) compared to RXL (12.08%). In terms of maximum drawdown, CURE dropped -69.19% vs RXL's -67.70%.

Which ETF is better, CURE or RXL?

On 10-year performance, CURE leads with 13.35% vs 12.62% for RXL. On fees, CURE is cheaper at 0.94% per year. On volatility, RXL has been the lower-risk option at 12.08%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, CURE or RXL?

Over the 10-year period, CURE has performed better with a 13.35% return vs 12.62%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, CURE or RXL?

CURE is cheaper with a 0.94% expense ratio, compared with 0.95% for RXL.

Which ETF pays a higher dividend yield, CURE or RXL?

RXL has the higher dividend yield at 1.28%, compared with 1.06% for CURE.

What is the main difference between CURE and RXL?

CURE tracks Health Care Select Sector Index (300%), while RXL tracks Dow Jones U.S. Health Care Index (200%). They also come from different issuers: Direxion and ProShares. Their fees differ too: 0.94% for CURE and 0.95% for RXL.

Which has better risk-adjusted returns?

CURE currently has the higher Sharpe Ratio (1.56 vs 1.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.